Callahan Advisors’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.2M Buy
49,373
+1,197
+2% +$430K 1.35% 26
2025
Q4
$16.9M Sell
48,176
-719
-1% -$262K 1.39% 22
2025
Q3
$18.1M Sell
48,895
-284
-0.6% -$110K 1.54% 18
2025
Q2
$19.5M Sell
49,179
-231
-0.5% -$86.4K 1.75% 14
2025
Q1
$18.4M Sell
49,410
-1,454
-3% -$553K 1.75% 15
2024
Q4
$18.3M Buy
50,864
+167
+0.3% +$61.9K 1.72% 15
2024
Q3
$18.3M Sell
50,697
-186
-0.4% -$64.2K 1.78% 15
2024
Q2
$17.3M Sell
50,883
-1,810
-3% -$613K 1.8% 16
2024
Q1
$18.9M Sell
52,693
-934
-2% -$314K 1.98% 14
2023
Q4
$16.1M Sell
53,627
-410
-0.8% -$115K 1.86% 17
2023
Q3
$14.8M Sell
54,037
-1,254
-2% -$360K 1.85% 17
2023
Q2
$16.9M Buy
55,291
+377
+0.7% +$109K 2.05% 13
2023
Q1
$15.7M Sell
54,914
-1,654
-3% -$439K 2.02% 16
2022
Q4
$13.8M Buy
56,568
+1,612
+3% +$366K 1.89% 18
2022
Q3
$11.1M Buy
54,956
+722
+1% +$152K 1.6% 21
2022
Q2
$10.8M Buy
54,234
+368
+0.7% +$86.4K 1.44% 22
2022
Q1
$14.4M Buy
53,866
+477
+0.9% +$123K 1.64% 20
2021
Q4
$14.3M Sell
53,389
-204
-0.4% -$53.5K 1.6% 20
2021
Q3
$14.1M Sell
53,593
-195
-0.4% -$52.1K 1.78% 16
2021
Q2
$14M Buy
53,788
+206
+0.4% +$52.7K 1.77% 16
2021
Q1
$13.1M Sell
53,582
-382
-0.7% -$91.6K 1.77% 18
2020
Q4
$13.2M Sell
53,964
-330
-0.6% -$74.7K 1.94% 18
2020
Q3
$11.3M Sell
54,294
-564
-1% -$110K 1.85% 21
2020
Q2
$9.88M Buy
54,858
+3,519
+7% +$649K 1.75% 19
2020
Q1
$8.55M Buy
51,339
+1,052
+2% +$206K 1.79% 19
2019
Q4
$10.6M Buy
50,287
+550
+1% +$114K 1.69% 22
2019
Q3
$10.8M Sell
49,737
-661
-1% -$142K 1.88% 20
2019
Q2
$10.4M Sell
50,398
-1,927
-4% -$368K 1.86% 22
2019
Q1
$10.3M Sell
52,325
-392
-0.7% -$70.5K 1.92% 20
2018
Q4
$8.26M Sell
52,717
-748
-1% -$125K 1.76% 26
2018
Q3
$9.5M Sell
53,465
-1,295
-2% -$221K 1.76% 25
2018
Q2
$9.25M Sell
54,760
-6,200
-10% -$1.04M 1.82% 22
2018
Q1
$9.81M Sell
60,960
-709
-1% -$114K 2.01% 16
2017
Q4
$9.55M Sell
61,669
-609
-1% -$92.9K 1.9% 19
2017
Q3
$8.85M Sell
62,278
-1,219
-2% -$175K 1.86% 21
2017
Q2
$8.81M Buy
63,497
+525
+0.8% +$72K 1.92% 22
2017
Q1
$8.29M Buy
62,972
+1,674
+3% +$211K 1.87% 24
2016
Q4
$7.34M Buy
61,298
+3,089
+5% +$355K 1.77% 25
2016
Q3
$6.78M Buy
58,209
+4,044
+7% +$471K 1.7% 26
2016
Q2
$6.49M Buy
54,165
+4,350
+9% +$486K 1.7% 26
2016
Q1
$5.34M Buy
49,815
+7,387
+17% +$728K 1.47% 31
2015
Q4
$3.94M Buy
42,428
+1,681
+4% +$161K 1.12% 37
2015
Q3
$3.83M Buy
40,747
+14,547
+56% +$1.44M 1.18% 37
2015
Q2
$2.5M Buy
26,200
+1,892
+8% +$179K 0.72% 53
2015
Q1
$2.24M Buy
24,308
+2,207
+10% +$205K 0.65% 54
2014
Q4
$2.08M Buy
22,101
+2,691
+14% +$239K 0.61% 56
2014
Q3
$1.57M Buy
19,410
+1,927
+11% +$159K 0.49% 66
2014
Q2
$1.47M Buy
17,483
+4,102
+31% +$335K 0.47% 66
2014
Q1
$1.09M Buy
13,381
+986
+8% +$78.4K 0.37% 73
2013
Q4
$931K Buy
12,395
+551
+5% +$40.2K 0.32% 77
2013
Q3
$801K Buy
11,844
+752
+7% +$51.9K 0.31% 78
2013
Q2
$717K Buy
+11,092
New +$736K 0.29% 76

Other funds holding SYK

Callahan Advisors's SYK Position: Q1 2026 in Review

Callahan Advisors increased its Stryker (SYK) stake by 2.5% in Q1 2026, buying an estimated $430K and bringing the position to 49,373 shares worth $16.2M. The position accounts for 1.35% of the portfolio, ranked #26.

Callahan Advisors first reported a position in SYK in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.5M in Q2 2025. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Callahan Advisors held 49,373 shares of Stryker worth $16.2M as of Q1 2026.
  • Callahan Advisors bought 1,197 Stryker shares in Q1 2026, an estimated $430K.
  • Stryker made up 1.35% of Callahan Advisors's portfolio in Q1 2026, its #26 holding.
  • Callahan Advisors first reported a position in Stryker in Q2 2013 and has held it in 52 quarters since.
  • Callahan Advisors's Stryker position peaked at $19.5M in Q2 2025.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Callahan Advisors's 13F filing for Q1 2026, filed 12 May 2026.